Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization
| Autor: | Ncdr, Sameer K. Mehta, Steven P. Marso, John S. Rumsfeld, John A. House, David J. Cohen, Jason B. Lindsey, John A. Spertus, Andrew D. Frutkin |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Percutaneous coronary intervention Revascularization Surgery Clinical Practice Coronary artery bypass surgery surgical procedures operative medicine.anatomical_structure Internal medicine Cohort Conventional PCI medicine Cardiology cardiovascular diseases business Cardiology and Cardiovascular Medicine Artery Surgical revascularization |
| Zdroj: | JACC: Cardiovascular Interventions. 2(7):614-621 |
| ISSN: | 1936-8798 |
| DOI: | 10.1016/j.jcin.2009.05.001 |
| Popis: | Objectives Our purpose was to evaluate percutaneous coronary intervention (PCI) attempt rates in patients with class I indications for coronary artery bypass graft (CABG) surgery after the introduction of drug-eluting stents (DES). Background In patients with severe, multivessel coronary disease, CABG has historically been recommended over PCI. Practice guidelines for CABG were last updated before the emergence of data on DES efficacy. Methods We analyzed 265,028 procedures from the NCDR (National Cardiovascular Data Registry) meeting American College of Cardiology/American Heart Association class I indications for surgical revascularization. Temporal trends in PCI attempt rates were analyzed during 3 consecutive time periods: pre-DES (before April 1, 2003), DES diffusion (April 1, 2003 to December 31, 2004), and DES (January 1, 2005 to September 30, 2006). Results The attempted rate of PCI in patients with class I indications for CABG increased over the 3 time periods (pre-DES: 29.4%, DES diffusion: 33.4%, and DES era: 34.7%, p Conclusions DES use in clinical practice was associated with a significant overall increase in PCI to treat patients with class I indications for CABG. Long-term follow-up of this cohort of patients is warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|